Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2007

Content (13 Articles)

Preclinical Study

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys

Charles E. Wood, Thomas C. Register, Cynthia J. Lees, Haiying Chen, Sabrina Kimrey, J. Mark Cline

Preclinical Study

Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells

A. Bellahcène, R. Bachelier, C. Detry, R. Lidereau, P. Clézardin, V. Castronovo

Preclinical study

The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells

William J. Brackenbury, Athina-Myrto Chioni, James K. J. Diss, Mustafa B. A. Djamgoz

Preclinical Study

Lewis x Antigen Mediates Adhesion of Human Breast Carcinoma Cells to Activated Endothelium. Possible Involvement of the Endothelial Scavenger Receptor C-type Lectin

María Teresa Elola, Mariana Isabel Capurro, María Marcela Barrio, Peter J. Coombs, Maureen E. Taylor, Kurt Drickamer, José Mordoh

Epidemiology

NSAID use and survival after breast cancer diagnosis in post-menopausal women

Cindy K. Blair, Carol Sweeney, Kristin E. Anderson, Aaron R. Folsom

Epidemiology

Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case–control study in Taiwan

Yu-Ching Chou, Meei-Shyuan Lee, Mei-Hsuan Wu, Hsiu-Lan Shih, Tsan Yang, Cheng-Ping Yu, Jyh-Cherng Yu, Chien-An Sun

Epidemiology

Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy

Kristie Long Foley, Gretchen Kimmick, Fabian Camacho, Edward A. Levine, Rajesh Balkrishnan, Roger Anderson

Epidemiology

Influence of Timing of Initiation of Adjuvant Chemotherapy Over Survival in Breast Cancer: A Negative Outcome Study by the Spanish Breast Cancer Research Group (GEICAM)

Carlos Jara Sánchez, Amparo Ruiz, Miguel Martín, Antonio Antón, Blanca Munárriz, Arrate Plazaola, José Schneider, Purificación Martínez del Prado, Emilio Alba, Antonio Fernández-Aramburo

Epidemiology

Correlates of physical activity level in breast cancer survivors participating in the Women’s Healthy Eating and Living (WHEL) Study

Suzi Hong, Wayne A. Bardwell, Loki Natarajan, Shirley W. Flatt, Cheryl L. Rock, Vicky A. Newman, Lisa Madlensky, Paul J. Mills, Joel E. Dimsdale, Cynthia A. Thomson, Richard A. Hajek, Janice A. Chilton, John P. Pierce

EPIDEMIOLOGY

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review

Valérie Bonadona, Sophie Dussart-Moser, Nicolas Voirin, Olga M Sinilnikova, Hervé Mignotte, Patrice Mathevet, Alain Brémond, Isabelle Treilleux, Alain Martin, Pascale Romestaing, Daniel Raudrant, René-Charles Rudigoz, Gilbert M. Lenoir, Christine Lasset

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine